BR9907644A - Formulação farmacêutica lìquida - Google Patents

Formulação farmacêutica lìquida

Info

Publication number
BR9907644A
BR9907644A BR9907644-6A BR9907644A BR9907644A BR 9907644 A BR9907644 A BR 9907644A BR 9907644 A BR9907644 A BR 9907644A BR 9907644 A BR9907644 A BR 9907644A
Authority
BR
Brazil
Prior art keywords
acid
pharmaceutical formulation
liquid pharmaceutical
liquid
zotepine
Prior art date
Application number
BR9907644-6A
Other languages
English (en)
Inventor
Ann Margaret Dyer
Alan Smith
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of BR9907644A publication Critical patent/BR9907644A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"FORMULAçãO FARMACêUTICA LìQUIDA" Uma formulação farmacêutica líquida compreendendo a) 2 a 7% p/ v de Zotepina; b) 0,5 a 35 % p/ v de um ácido orgânico selecionado do grupo consistindo de ácido ascórbico, ácido cítrico, ácido fumárico, acido glutárico, ácido láctico, ácido málico, ácido sórbico e ácido tartárico; 15 a 60% v / v de etanol e d) um diluente líquido para completar 100 %, que pode ser usada em gotas ou em uma bebida.
BR9907644-6A 1998-02-07 1999-01-27 Formulação farmacêutica lìquida BR9907644A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802617.2A GB9802617D0 (en) 1998-02-07 1998-02-07 Pharmaceutical formulation
PCT/EP1999/000533 WO1999039709A1 (en) 1998-02-07 1999-01-27 Liquid pharmaceutical formulation containing zotepine

Publications (1)

Publication Number Publication Date
BR9907644A true BR9907644A (pt) 2000-11-14

Family

ID=10826622

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907644-6A BR9907644A (pt) 1998-02-07 1999-01-27 Formulação farmacêutica lìquida

Country Status (25)

Country Link
US (1) US6239165B1 (pt)
EP (1) EP1054666B1 (pt)
JP (1) JP2002502818A (pt)
KR (1) KR20010040717A (pt)
AR (1) AR018062A1 (pt)
AT (1) ATE227988T1 (pt)
AU (1) AU2720099A (pt)
BG (1) BG104682A (pt)
BR (1) BR9907644A (pt)
CA (1) CA2320475A1 (pt)
CO (1) CO4970815A1 (pt)
CZ (1) CZ291975B6 (pt)
DE (1) DE69904021T2 (pt)
DK (1) DK1054666T3 (pt)
ES (1) ES2188135T3 (pt)
GB (1) GB9802617D0 (pt)
HK (1) HK1033088A1 (pt)
HR (1) HRP20000579A2 (pt)
HU (1) HUP0100769A3 (pt)
PL (1) PL342213A1 (pt)
PT (1) PT1054666E (pt)
SK (1) SK11472000A3 (pt)
TR (1) TR200002288T2 (pt)
WO (1) WO1999039709A1 (pt)
ZA (1) ZA99918B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1247067A (en) * 1968-02-16 1971-09-22 Fujisawa Pharmaceutical Co Tricyclic enol ether compounds and the preparation thereof
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja) * 1981-09-24 1983-03-28 Fujisawa Pharmaceut Co Ltd 血清尿酸値低下剤
JPH07116039B2 (ja) * 1988-01-11 1995-12-13 オール薬品工業株式会社 安定な塩酸トリメトキノール内用液剤
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
IL117612A0 (en) * 1995-03-24 1996-07-23 Lilly Co Eli Granule formulation for olanzapine
GB9526264D0 (en) * 1995-12-21 1996-02-21 Knoll Ag Medical treatment
JPH09286723A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤

Also Published As

Publication number Publication date
HUP0100769A2 (hu) 2001-12-28
EP1054666A1 (en) 2000-11-29
SK11472000A3 (sk) 2001-08-06
US6239165B1 (en) 2001-05-29
ZA99918B (en) 2000-08-07
CZ20002846A3 (cs) 2000-12-13
ES2188135T3 (es) 2003-06-16
KR20010040717A (ko) 2001-05-15
TR200002288T2 (tr) 2000-12-21
WO1999039709A1 (en) 1999-08-12
HRP20000579A2 (en) 2001-04-30
HK1033088A1 (en) 2001-08-17
DE69904021D1 (de) 2003-01-02
HUP0100769A3 (en) 2002-04-29
CA2320475A1 (en) 1999-08-12
AU2720099A (en) 1999-08-23
CO4970815A1 (es) 2000-11-07
EP1054666B1 (en) 2002-11-20
GB9802617D0 (en) 1998-04-01
ATE227988T1 (de) 2002-12-15
DK1054666T3 (da) 2003-03-17
PT1054666E (pt) 2003-03-31
DE69904021T2 (de) 2003-04-30
BG104682A (en) 2001-05-31
AR018062A1 (es) 2001-10-31
CZ291975B6 (cs) 2003-06-18
JP2002502818A (ja) 2002-01-29
PL342213A1 (en) 2001-05-21

Similar Documents

Publication Publication Date Title
RS49609B (sr) Stabilizovani antihistaminski sirup
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
HRP20030870B1 (en) Aripiprazole oral solution
EP0265202A3 (en) Disinfectant compositions
HUP0203836A3 (en) 1,3-disubstituted pyrrololidines as alpha-2-adrenoceptor antagonists, process for their preparation and pharmaceutical compositions containing them and their use
DE69533470D1 (de) Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält
DE69618207D1 (de) Zusammensetzungen zur topischen abgabe von aktiven wirkstoffen
NO874038D0 (no) Fortykkede vandige rengjoeringspreparater.
CA2177492A1 (en) Preparation of hollow microcapsules
NO20024339D0 (no) 1,2,3,4-Tetrahydroisokinolin-derivater
IT1313618B1 (it) Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione.
DK0542059T3 (da) Substituerede biphenylpyridoner som angiotensin II-antagonister
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
PL344042A1 (en) Compounds with growth hormone releasing properties
CA2338794A1 (en) New oral formulation for 5-ht4 agonists or antagonists
AU4623396A (en) 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
FR2804286B1 (fr) Utilisation de derives de polyaminoacides comme agents conservateurs, compositions les comprenant et procede de conservation les utilisant
FR2663326B2 (fr) Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
WO2002024665A8 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
BR9907644A (pt) Formulação farmacêutica lìquida
IL137794A0 (en) Streptogramin derivatives, preparation method and compositions containing same
ATE75395T1 (de) Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.